| P50 | author | Michael R. Hayden | Q6833706 |
| | Colin J. Ross | Q40650205 |
| | Frank G. Schaap | Q42394202 |
| | Patrick Rensen | Q71803041 |
| P2093 | author name string | J A Kuivenhoven | |
| | G M Dallinga-Thie | |
| | L W Castellani | |
| | S F C Vaessen | |
| | L J Splint | |
| P2860 | cites work | Apolipoprotein A-V: a novel apolipoprotein associated with an early phase of liver regeneration | Q24291737 |
| | An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing | Q24291759 |
| | Apolipoprotein A-V interaction with members of the low density lipoprotein receptor gene family | Q24298481 |
| | Lipoprotein ApoC-II activation of lipoprotein lipase. Modulation by apolipoprotein A-IV | Q24301117 |
| | Apolipoprotein A-V-heparin interactions: implications for plasma lipoprotein metabolism | Q24301565 |
| | The novel apolipoprotein A5 is present in human serum, is associated with VLDL, HDL, and chylomicrons, and circulates at very low concentrations compared with other apolipoproteins | Q24311849 |
| | Severe hypertriglyceridemia in human APOC1 transgenic mice is caused by apoC-I-induced inhibition of LPL | Q24319030 |
| | Endocytosis of apolipoprotein A-V by members of the low density lipoprotein receptor and the VPS10p domain receptor families | Q24651670 |
| | Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels | Q28213595 |
| | Characterization of apolipoprotein A-V structure and mode of plasma triacylglycerol regulation | Q28301814 |
| | Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice. Mild hypertriglyceridemia with impaired very low density lipoprotein clearance in heterozygotes | Q35767590 |
| | Give me A5 for lipoprotein hydrolysis! | Q36274976 |
| | Apolipoprotein AII is a regulator of very low density lipoprotein metabolism and insulin resistance | Q39262850 |
| | Inherited apolipoprotein A-V deficiency in severe hypertriglyceridemia | Q39369438 |
| | Apolipoprotein A-V, triglycerides and risk of coronary artery disease: the prospective Epic-Norfolk Population Study | Q40316899 |
| | Interchange of apolipoproteins between chylomicrons and high density lipoproteins during alimentary lipemia in man. | Q40371487 |
| | Apolipoprotein AV accelerates plasma hydrolysis of triglyceride-rich lipoproteins by interaction with proteoglycan-bound lipoprotein lipase. | Q40445575 |
| | Abnormal patterns of lipoprotein lipase release into the plasma in GPIHBP1-deficient mice. | Q41177026 |
| | Long-term correction of murine lipoprotein lipase deficiency with AAV1-mediated gene transfer of the naturally occurring LPL(S447X) beneficial mutation | Q44050329 |
| | Influence of the APOA5 locus on plasma triglyceride, lipoprotein subclasses, and CVD risk in the Framingham Heart Study | Q45041089 |
| | Hypertriglyceridaemia and low plasma HDL in a patient with apolipoprotein A-V deficiency due to a novel mutation in the APOA5 gene | Q46715156 |
| | Effect of apolipoprotein A-V on plasma triglyceride, lipoprotein size, and composition in genetically engineered mice | Q47258780 |
| | Association of the APOLIPOPROTEIN A1/C3/A4/A5 gene cluster with triglyceride levels and LDL particle size in familial combined hyperlipidemia | Q47426824 |
| | ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis | Q47748338 |
| | Altered apolipoprotein A-V expression during the acute phase response is independent of plasma triglyceride levels in mice and humans. | Q52935687 |
| | The apolipoprotein A-V genotype and plasma apolipoprotein A-V and triglyceride levels: prospective risk of type 2 diabetes. Results from the Northwick Park Heart Study II. | Q53590471 |
| | Plasma apolipoprotein A5 and triglycerides in type 2 diabetes | Q57365063 |
| | Changes in Hepatic ApoAV Expression are not Required for the Rapid Triglyceride Lowering Effect of Fish Oil Diet in Rats | Q61978260 |
| | Relationship of apolipoprotein A5 and apolipoprotein C3 levels to serum triglycerides in patients with type 2 diabetes | Q79450862 |
| | The increase of apolipoprotein A-V during postprandial lipemia parallels the response of triglyceride-rich lipoproteins in type 2 diabetes: no relationship between apoA-V and postheparin plasma lipolytic activity | Q80280808 |
| P433 | issue | 5 | |
| P921 | main subject | triglyceride | Q186319 |
| P304 | page(s) | 880-884 | |
| P577 | publication date | 2009-01-13 | |
| P1433 | published in | Journal of Lipid Research | Q6295449 |
| P1476 | title | Plasma apolipoprotein AV levels in mice are positively associated with plasma triglyceride levels | |
| P478 | volume | 50 | |